Head-to-head · free

GE HealthCare vs Johnson & Johnson

GEHC vs JNJ — return on capital, cash generation, margins and balance sheet side by side.

GEHC

0 / 8

measures where GEHC leads

JNJ

8 / 8

measures where JNJ leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureGEHC · FY2025JNJ · FY2025
Revenue$20.6B$94.2B
Net income$2.1B$26.8B
Revenue growth (yearly, multi-year)2.7%3.3%
Free cash flow—$19.7B
Free cash flow margin—20.9%
Net cash / (debt)——
ROIC10.8%21.1%
Return on equity22.1%35.0%
Gross margin40.0%67.9%
Operating margin13.4%27.2%
Net debt / EBITDA1.65x0.73x

Figures are as reported by each company; latest fiscal year shown.

Where GE HealthCare's cash went (FY2025)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full GEHC profile →

Where Johnson & Johnson's cash went (FY2025)

Capital spending
$4.8B
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full JNJ profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons